Regeneron Pharmaceuticals (REGN) Current Assets (2009 - 2026)
Regeneron Pharmaceuticals' Current Assets was $18.45 billion in Q2 2026, up 9.4% from $16.86 billion a year earlier and up 1.3% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Regeneron Pharmaceuticals came in at $18.02 billion, down 3.4% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- In earlier years, Current Assets was $18.66 billion in FY2024 (-4.2%), $19.48 billion in FY2023 (+22.6%), $15.88 billion in FY2022 (+13.3%) and $14.01 billion in FY2021 (+43.3%).
- The Q2 2026 figure marks the highest quarterly Current Assets since Q4 2024.
- Compared with a year earlier, Current Assets was higher in three of the last eight quarters, with an average decline of 2.0%.
- The best year-over-year quarter for Current Assets over five years was Q3 2021 (growth of 51.4%); the worst was Q2 2025 (a decline of 11.6%).
- Per Business Quant data, REGN's Current Assets in the three quarters before Q2 2026 was $18.21 billion (Q1 2026), $18.02 billion (Q4 2025) and $17.98 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 18.45 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.45 Bn |
| Mar 31, 2026 | 18.21 Bn |
| Dec 31, 2025 | 18.02 Bn |
| Sep 30, 2025 | 17.98 Bn |
| Jun 30, 2025 | 16.86 Bn |
| Mar 31, 2025 | 17.57 Bn |
| Dec 31, 2024 | 18.66 Bn |
| Sep 30, 2024 | 19.33 Bn |
| Jun 30, 2024 | 19.08 Bn |
| Mar 31, 2024 | 18.87 Bn |
| Dec 31, 2023 | 19.48 Bn |
| Sep 30, 2023 | 18.63 Bn |
| Jun 30, 2023 | 16.92 Bn |
| Mar 31, 2023 | 16.91 Bn |
| Dec 31, 2022 | 15.88 Bn |
| Sep 30, 2022 | 15.43 Bn |
| Jun 30, 2022 | 15.53 Bn |
| Mar 31, 2022 | 14.31 Bn |
| Dec 31, 2021 | 14.01 Bn |
| Sep 30, 2021 | 13.78 Bn |
API Access
Regeneron Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();